Abstract:Reported is a facile and efficient Methodology toward the synthesis of novel pyrimidine-fused spiropyrrolidine oxindoles via a multicomponent 1,3-dipolar cycloaddition reaction of pyrimidine-fused 3-alkenyloxindoles I with azomethine ylides (thermally generated in situ from sarcosine and formaldehyde). Products bearing adjacent quaternary-tertiary centers were smoothly obtained in high yields (up to 90% yield) with good diastereoselectivity (up to >20:1). In addition, their biological activity has been preliminarily demonstrated by in vitro evaluation against human lung cancer cells A549, human prostate cancer cells PC-3, and human leukemia cells 1<562 by the MIT-based assays, using the commercially available broad-spectrum anticancer drug of Cisplatin as a positive control. The results also demonstrated that most of the compounds showed considerable cytotoxicities to these three cell lines of 1<562, PC-3, and A549, showed comparably potent or even more potent than the positive control of Cisplatin (up to 3.0 times), and indicated that novel pyrimidine-fused spiropyrrolidine oxindoles may be potential leads for further biological screenings and may generate drug-like molecules. (C) 2016 Elsevier Ltd. All rights reserved.

Synthesis of Diversely Substituted Imidazolidines <i>via</i> [3+2] Cycloaddition of 1,3,5-Triazinanes with Donor-Acceptor Aziridines and Their Anti-Tumor Activity

Synthesis of Diversely Substituted Imidazolidines via [3+2] Cycloaddition of 1,3,5‐Triazinanes with Donor‐acceptor Aziridines and Their Anti‐tumor Activity

Cross 1,3-dipolar cycloadditions of C,N-cyclic azomethine imines with an N-benzyl azomethine ylide: facile access to fused tricyclic 1,2,4-hexahydrotriazines

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Diastereo‐ and Enantioselective Silver‐Catalyzed [3+3] Cycloaddition and Kinetic Resolution of Azomethine Imines with Activated Isocyanides

Access to Imidazolidines Via 1,3-Dipolar Cycloadditions of 1,3,5-Triazinanes with Aziridines.

Diversity‐Oriented Synthesis of Functionalized Imidazopyridine Analogues with Anti‐Cancer Activity Through a Transition‐Metal Free, One‐pot Cascade Reaction

Synthesis of Imidazo[1,2-a]pyridine-Fused 1,3-Benzodiazepine Derivatives with Anticancer Activity Via a One-Pot Cascade GBB-3CR/Pd(II)-Catalyzed Azide-Isocyanide Coupling/Cyclization Process.

Y(OTf)3-Catalyzed Diastereoselective [3+2] Cycloaddition of N-Tosylaziridines and Imines; Efficient Synthesis of Multisubstituted Imidazolidines

1,3-Dipolar Cycloaddition of Imidazole Derivatives with Nitrile Oxide: Synthesis of Imidazo[1,2,4]oxadiazole Derivatives

Synthesis of 1,3,5-Trisubstituted Pyrazole-4-carboxylates Through 1,3-Dipolar Cycloaddition of Nitrilimines with Allenoates

[3 + 2] cycloaddition of nonstabilized azomethine ylides and 2-benzothiazolamines to access imidazolidine derivatives

Diversity-Oriented Synthesis of Imidazo-Dipyridines with Anticancer Activity Via the Groebke–Blackburn–Bienaymé and TBAB-Mediated Cascade Reaction in One Pot

TBAF-Mediated [3+1] Cycloaddition of Difluorocarbene to Access Gem-Difluorinated 1,2-Diazetidine Analogues As Potent Anticancer Agents.

Synthesis of 2-(Trifluoromethyl)-[1,2,4]triazolo[5,1-a]isoquinoline Via Cycloaddition of C,N-Cyclic Azomethine Imine with CF3CN.

Synthesis of 4-Tetrazolyl-substituted 3,4-Dihydroquinazoline Derivatives with Anticancer Activity Via a One-Pot Sequential Ugi-Azide/Palladium-Catalyzed Azide-Isocyanide Cross-Coupling/Cyclization Reaction

Advance in Synthesis of Imidazoline by [3+2]-Cycloaddition of N-tosyl Aziridines with nitriles

Synthesis of Antitumor 3,4,6,7-Tetrahydro-2h-pyrimido[1,6-c]quinazolin-2-imine Derivatives Via Reductive Dearomatization-Initiated Intramolecular Cyclization

Synthesis and Antitumor Activity of 5,6-2H-[1,2,4]-Triazolo [3,4-b][1,3,4]thiadiazine Derivatives

Molecular Hybridization-Guided 1,3-Dipolar Cycloaddition Reaction Enabled Pyrimidine-Fused Spiropyrrolidine Oxindoles Synthesis As Potential Anticancer Agents

Regio- and stereoselective synthesis and evaluation of densely functionalized bispiro[oxindole-isoxazole-indandione] hybrids as anticancer agents